Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Dehydration, Diarrhoea, Fatigue
Clinical narrative: Dehydration; Decreased appetite; Headache; fever; Nausea; substantial diarrhea; Fatigue; Chills; This is a spontaneous report received from a Consumer or other non HCP.  A female patient (unknown if pregnant) received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 08Sep2024 as dose 1, single (Batch/Lot number: unknown) intramuscular, in left arm for covid-19 immunisation; influenza vaccine rha 3v (baculovirus) (FLUBLOK), on 08Sep2024 as dose 1, single), in right arm for immunisation. The patient's relevant medical history included: "Food allergy" (ongoing); "Drug hypersensitivity" (ongoing); "Childhood asthma" (ongoing). Concomitant medication(s) included: ADVAIR taken for asthma; SPIRIVA taken for asthma; CLARITIN [LORATADINE] taken for hypersensitivity. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Lot: EN6198, Left arm), administration date: 18Mar2021, for COVID-19 immunization; BNT162b2 (DOSE 2, SINGLE, Lot: EP7533, Left arm), administration date: 04Aug2021, for COVID-19 immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE, Lot: FJ1611, Left arm), administration date: 20Nov2021, for COVID-19 immunization. The following information was reported: CHILLS (hospitalization) with onset 2024, outcome "recovered" (2024); DECREASED APPETITE (hospitalization) with onset 2024, outcome "recovered" (2024); DEHYDRATION (hospitalization) with onset 2024, outcome "recovered" (2024); FATIGUE (hospitalization) with onset 2024, outcome "recovered" (2024); HEADACHE (hospitalization) with onset 2024, outcome "recovered" (2024); NAUSEA (hospitalization) with onset 2024, outcome "recovered" (2024); PYREXIA (hospitalization) with onset 2024, outcome "recovered" (2024), described as "fever"; DIARRHOEA (hospitalization) with onset 2024, outcome "recovered" (2024), described as "substantial diarrhea". The patient was hospitalized for dehydration, decreased appetite, headache, pyrexia, nausea, diarrhoea, fatigue, chills (start date: 2024, discharge date: 2024, hospitalization duration: 1 day(s)).  Additional information: The patient's past medical treatment(s) and family history were not provided. On 08-Sep-2024, the patient received unknown dose (dose 1) of suspect Influenza quadrivalent recombinant vaccine (formulation, strength, lot number and expiry date not reported) via unknown route in the right arm and unknown dose (dose 1) of suspect COMIRNATY not produced by Sanofi Pasteur (formulation, strength, lot number and expiry date not reported) via intramuscular route in the left arm both for prophylactic vaccination.There will be no information available on the batch number for this case. On an unknown date the patient developed dehydration, headache, fever (pyrexia), nausea, decreased appetite, substantial diarrhea (diarrhoea), fatigue and chills (unknown latency). The patient was hospitalized for the events during 1 days. (hospitalization during 1 days). It was not reported if the patient received a corrective treatment for all the events. At the time of reporting, the outcome was recovered/resolved on an unknown date for all the events.  No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.